Cargando…

Improving intermittent androgen deprivation therapy: lessons learned from basic and translational research

Intermittent androgen deprivation therapy (IADT) is an alternative to continuous androgen deprivation therapy (ADT) in prostate cancer patients with nonmetastatic disease. ADT is associated with numerous side effects such as hot flashes, sexual dysfunction, anemia, fatigue, loss of muscle mass, oste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parikh, Rahul A, Pascal, Laura E, Davies, Benjamin J, Wang, Zhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Invited Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104071/ https://www.ncbi.nlm.nih.gov/pubmed/24759577 http://dx.doi.org/10.4103/1008-682X.125410

Ejemplares similares

Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation
por: Lipianskaya, Julia, et al.
Publicado: (2014)

Translating Basic Research on the Aging Family to Caregiving Intervention: The Case of Within-Family Differences
por: Pillemer, Karl, et al.
Publicado: (2018)

The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment
por: Ku, Ja Yoon, et al.
Publicado: (2015)

PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance
por: Edlind, Merritt P, et al.
Publicado: (2014)

Androgen deprivation therapy in castrate-resistant prostate cancer: how important is GnRH agonist backbone therapy?
por: Merseburger, Axel S., et al.
Publicado: (2014)

Speaking the Same Language: Team Science Approaches in Aging Research for Integrating Basic and Translational Science With Clinical Practice
por: Sukoff Rizzo, Stacey J, et al.
Publicado: (2023)

Intermittent androgen deprivation therapy: recommendations to improve the management of patients with prostate cancer following the GRADE approach
por: Bonfill, Xavier, et al.
Publicado: (2018)

Benefits of intermittent/continuous androgen deprivation in patients with advanced prostate cancer
por: MURESANU, HORIA
Publicado: (2016)

Intermittent androgen deprivation therapy in patients with prostate cancer: Connecting the dots
por: Abrahamsson, Per-Anders
Publicado: (2017)

MANAGEMENT OF ABC: LESSONS LEARNED FROM COVID-19
por: Biganzoli, Laura
Publicado: (2021)

Improving methods to evaluate the impacts of plant invasions: lessons from 40 years of research
por: Stricker, Kerry Bohl, et al.
Publicado: (2015)

Prostate-specific antigen dynamics predict individual responses to intermittent androgen deprivation
por: Brady-Nicholls, Renee, et al.
Publicado: (2020)

Association between SARS-CoV-2 infection and disease severity among prostate cancer patients on androgen deprivation therapy: a systematic review and meta-analysis
por: Sari Motlagh, Reza, et al.
Publicado: (2021)

Intermittent Androgen Suppression: Estimating Parameters for Individual Patients Based on Initial PSA Data in Response to Androgen Deprivation Therapy
por: Hirata, Yoshito, et al.
Publicado: (2015)

Androgens and prostate disease
por: Cooper, Lori A, et al.
Publicado: (2014)

Cardiovascular Impact of Androgen Deprivation Therapy: from Basic Biology to Clinical Practice
por: Kim, Janice, et al.
Publicado: (2023)

Strategies for myelin regeneration: lessons learned from development
por: Bhatt, Abhay, et al.
Publicado: (2014)

Long-term field studies in bat research: importance for basic and applied research questions in animal behavior
por: Kerth, Gerald
Publicado: (2022)

Human androgen deficiency: insights gained from androgen receptor knockout mouse models
por: Rana, Kesha, et al.
Publicado: (2014)

Inter-departmental dosimetry audits – development of methods and lessons learned
por: Eaton, David J., et al.
Publicado: (2015)

CAR T cells for brain tumors: Lessons learned and road ahead
por: Akhavan, David, et al.
Publicado: (2019)

Hydroxychloroquine and COVID-19: a Rheumatologist’s Take on the Lessons Learned
por: Udupa, Akrithi, et al.
Publicado: (2021)

Lessons learned from Chikungunya
por: Rezza, Giovanni
Publicado: (2010)

Androgens and estrogens in skeletal sexual dimorphism
por: Laurent, Michaël, et al.
Publicado: (2014)

Impact of taxanes on androgen receptor signaling
por: Bai, Shanshan, et al.
Publicado: (2019)

Lessons learned from the search for genes responsible for rare Mendelian disorders
por: Sobreira, Nara L., et al.
Publicado: (2016)

Improving access to psychological treatments: Lessons from developing countries
por: Patel, Vikram, et al.
Publicado: (2011)

Relugolix – The novel oral androgen deprivation therapy for prostate cancer
por: Jena, Rahul
Publicado: (2020)

Male androgen deficiency: a multisystem syndrome
por: Grossmann, Mathis, et al.
Publicado: (2014)

AB37. The combination of I brachytherapy with intermittent androgen deprivation in treating locally advanced prostate cancer
por: Huang, Yi
Publicado: (2014)

Septic acute kidney injury: a review of basic research
por: Nakano, Daisuke
Publicado: (2020)

Translational research at acute HIV Infection
por: Routy, Jean Pierre
Publicado: (2010)

Total en bloc spondylectomy for spinal tumors: improvement of the technique and its associated basic background
por: Tomita, Katsuro, et al.
Publicado: (2006)

Examining the impact of COVID‐19 on cardiac surgery services: The lessons learned from this pandemic
por: Harky, Amer, et al.
Publicado: (2020)

What’s Hot in HIV in 2019—A Basic and Translational Science Summary for Clinicians From IDWeek 2019
por: Titanji, Boghuma, et al.
Publicado: (2020)

Approach to androgen excess in women: Clinical and biochemical insights
por: Cussen, Leanne, et al.
Publicado: (2022)

Pathology in Africa: back to basics
por: Slootweg, Pieter J.
Publicado: (2012)

Long-term treatment outcomes of intermittent androgen deprivation therapy for relapsed prostate cancer after radical prostatectomy
por: Maru, Shintaro, et al.
Publicado: (2018)

Androgen effects on skeletal muscle: implications for the development and management of frailty
por: O’Connell, Matthew DL, et al.
Publicado: (2014)

Androgen synthesis inhibitors in the treatment of castration-resistant prostate cancer
por: Stein, Mark N, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_iruv2g0ncktbhobvkqililkqbg